Oncotelic Initiates Clinical Trials Evaluating OT-101 against Metastatic Pancreatic Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. DELL
2. MDT
3. SPY
4. PANW
5. AAPL
6. USO
7. SPGI
8. ENOV
9. GTLB
10. NIO

Go back to Oncotelic Initiates Clinical Trials Evaluating OT-101 against Metastatic Pancreatic Cancer
(AMEX: OTLC) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High $ 
Open $0.03    52 Week Low $ 
Day High $0.03    P/E N/A 
Day Low $0.03    EPS $ 
Volume 223